Euromed S.A.

Euromed-S.A.jpg

Founded in 1971 by the German pharmaceutical company Madaus, EUROMED S.A., now with Dermapharm Group, is a vertically integrated leading producer of premium standardized botanical extracts and natural active ingredients, for the global pharmaceutical, nutraceutical, food and cosmetic industries.

EUROMED identifies, cultivates and harvests the finest raw botanicals, which we transform into high-quality extracts. Our supply chain is transparent and traceable from seed to final extract. All extracts comply with worldwide GMP(Good Manufacturing Practice)norms, international pharmacopoeias and regulations.

Annually, a biomass of more than 5000 tons is extracted at our manufacturing facilities in Mollet del Vallès (Barcelona) and Molina de Segura (Murcia), Spain. The new production plant in Murcia further expands EUROMED's capabilities with eco-friendly technologies: a proprietary water-based extraction, the Pure-Hydro Process™, prevents the release of potential contaminants into the environment, creating a natural product free from organic solvent-related safety concerns.

EUROMED has extensive experience in the areas of research and development, laboratory analysis and extraction technologies and is committed to the highest quality standards in terms of analytical, chemical and evidence-based therapeutic aspects.

Our 50 years expertise in manufacturing pharmaceutical-grade extracts for the healthcare professional market is now available for the fast-growing nutraceutical market.

Related Resources

Pomanox® and Pomalive®: nature's solution for heart health

Pomanox® and Pomalive®: nature's solution for heart health

Content provided by Euromed S.A.

Product Brochure

A recent human study confirms punicalagin rich pomegranate extract Pomanox® may enhance cardiovascular health, maintaining normal blood pressure, healthy carbohydrate metabolism and body composition.

Pomanox® and Spisar®: Sports Nutrition & Weight Management

Pomanox® and Spisar®: Sports Nutrition & Weight Management

Content provided by Euromed S.A.

White Paper

Pomanox® intake (210 mg punicalagin daily) for 14 days significantly increased time to exhaustion and time to reach ventilatory threshold 2 (VT2) in a maximal test following a sustained endurance effort, compared with placebo. Promotion of satiety,...